Curis Inc
Veridion Score
BETALOW CONF · 4/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is CRIS moving today?
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
CRIS overview
Related filings and maps
Congress activity in CRIS
No receipt-qualified Congressional disclosure is present for CRIS in the cached public ledger.
CRIS contract awards, year to date.
Public federal awards linked to this ticker.
CRIS lobbying filings, year to date.
Registered lobbying filings matched to Curis Inc.